Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28866
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShembrey, Carolyn-
dc.contributor.authorSmith, Jai-
dc.contributor.authorGrandin, Mélodie-
dc.contributor.authorWilliams, Nathalia-
dc.contributor.authorCho, Hyun-Jung-
dc.contributor.authorMølck, Christina-
dc.contributor.authorBehrenbruch, Corina-
dc.contributor.authorThomson, Benjamin Nj-
dc.contributor.authorHeriot, Alexander G-
dc.contributor.authorMerino, Delphine-
dc.contributor.authorHollande, Frédéric-
dc.date2022-
dc.date.accessioned2022-02-22T04:30:47Z-
dc.date.available2022-02-22T04:30:47Z-
dc.date.issued2022-01-24-
dc.identifier.citationCancers 2022; 14(3): 581en
dc.identifier.issn2072-6694
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28866-
dc.description.abstractGeno- and phenotypic heterogeneity amongst cancer cell subpopulations are established drivers of treatment resistance and tumour recurrence. However, due to the technical difficulty associated with studying such intra-tumoural heterogeneity, this phenomenon is seldom interrogated in conventional cell culture models. Here, we employ a fluorescent lineage technique termed "optical barcoding" (OBC) to perform simultaneous longitudinal tracking of spatio-temporal fate in 64 patient-derived colorectal cancer subclones. To do so, patient-derived cancer cell lines and organoids were labelled with discrete combinations of reporter constructs, stably integrated into the genome and thus passed on from the founder cell to all its clonal descendants. This strategy enables the longitudinal monitoring of individual cell lineages based upon their unique optical barcodes. By designing a novel panel of six fluorescent proteins, the maximum theoretical subpopulation resolution of 64 discriminable subpopulations was achieved, greatly improving throughput compared with previous studies. We demonstrate that all subpopulations can be purified from complex clonal mixtures via flow cytometry, permitting the downstream isolation and analysis of any lineages of interest. Moreover, we outline an optimized imaging protocol that can be used to image optical barcodes in real-time, allowing for clonal dynamics to be resolved in live cells. In contrast with the limited intra-tumour heterogeneity observed in conventional 2D cell lines, the OBC technique was successfully used to quantify dynamic clonal expansions and contractions in 3D patient-derived organoids, which were previously demonstrated to better recapitulate the heterogeneity of their parental tumour material. In summary, we present OBC as a user-friendly, inexpensive, and high-throughput technique for monitoring intra-tumoural heterogeneity in in vitro cell culture models.en
dc.language.isoeng
dc.subjectcell culture techniquesen
dc.subjectcell lineageen
dc.subjectclonal evolutionen
dc.subjectcolorectal neoplasmsen
dc.subjectlongitudinal imagingen
dc.subjectmetastasisen
dc.subjectneoplasm recurrenceen
dc.subjectorganoidsen
dc.subjectself-renewalen
dc.subjecttumour heterogeneityen
dc.titleLongitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models.en
dc.typeJournal Articleen
dc.identifier.journaltitleCancersen
dc.identifier.affiliationDepartment of Surgery, St Vincent's Hospital, Melbourne, VIC 3065, Australia..en
dc.identifier.affiliationDepartment of Medical Biology, The Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Melbourne, VIC 3010, Australia..en
dc.identifier.affiliationBiological Optical Microscopy Platform, University of Melbourne, Melbourne, VIC 3010, Australia..en
dc.identifier.affiliationDepartment of General Surgical Specialties, The Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC 3050, Australia..en
dc.identifier.affiliationDepartment of Surgery, the Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC 3050, Australia..en
dc.identifier.affiliationThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3010, Australia..en
dc.identifier.affiliationDepartment of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia..en
dc.identifier.affiliationDepartment of Clinical Pathology, University of Melbourne, Melbourne, VIC 3000, Australia..en
dc.identifier.affiliationVictorian Comprehensive Cancer Centre, University of Melbourne Centre for Cancer Research, Melbourne, VIC 3000, Australia..en
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia..en
dc.identifier.affiliationImmunology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC 3052, Australia..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35158849/en
dc.identifier.doi10.3390/cancers14030581en
dc.type.contentTexten
dc.identifier.orcid0000-0003-4997-6189en
dc.identifier.orcid0000-0003-2279-5302en
dc.identifier.orcid0000-0002-2932-1890en
dc.identifier.orcid0000-0002-7046-8392en
dc.identifier.orcid0000-0002-8075-6275en
dc.identifier.pubmedid35158849
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

24
checked on Jan 21, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.